Pharmacological management of common urodynamic problems.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004775:Enuresis / Q000188:drug therapy; D005260:Female; D005422:Flavoxate / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D010276:Parasympatholytics / Q000627:therapeutic use*; D014521:Urethra / Q000187:drug effects; D001743:Urinary Bladder / Q000187:drug effects; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy; D014549:Urinary Incontinence / Q000188:drug therapy; D014555:Urination Disorders / Q000188:drug therapy*
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000929:Antidepressive Agents, Tricyclic; D010276:Parasympatholytics; D001971:Bromocriptine; D005422:Flavoxate; D003975:Diazepam